Bimatoprost Solution/ Drops
Product Images NDC 60219-2149

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bimatoprost (NDC 60219-2149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Bimatoprost Ophthalmic Solution 1)

FDA Label Image

001 (Bimatoprost Ophthalmic Solution 2)

This text provides information about a prescription eye medication with the active ingredient Bimatoprost. It includes the recommended dosage of one drop in the affected eye(s) once daily in the evening. The solution contains benzalkonium chloride as a preservative. The storage instructions advise keeping it at 2° to 25°C. The medication is distributed by Amneal Pharmaceuticals LLC and is produced in India.*

FDA Label Image

002 (Bimatoprost Ophthalmic Solution 3)

This is a description for an ophthalmic solution in a sterile 25mL bottle. It is recommended for eye use only, with instructions for adjusting pH if needed. The recommended dosage is one drop in the affected eye(s) daily in the evening. The storage temperature is specified as between 2°C to 25°C. The solution contains active ingredient Bimatoprost and Benzalkonium Chloride, along with other inactive ingredients. The manufacturer is Amneal Pharmaceuticals LLC. The product is meant for prescription use only.*

FDA Label Image

003 (Bimatoprost Ophthalmic Solution 4)

This text provides information about a medication with the active ingredient Bimatoprost in a concentration of 0.1 mg per mL. It includes details on the preservative (Benzalkonium chloride) and the recommended dosage of one drop in the affected eye(s) daily in the evening. The storage conditions, sterile nature, and manufacturer details are also mentioned. This medication is distributed by Amneal Pharmaceuticals LLC, and it is manufactured in India. The text specifies the dimensions for unvarnished area and mentions batch coding details.*

FDA Label Image

004 (Bimatoprost Ophthalmic Solution 5)

This is a description of a Bimatoprost Ophthalmic Solution used for eye care. The solution is sterile and is recommended for use once daily in the evening. It contains active ingredients like Bimatoprost and Benzalkonium chloride. The storage temperature is advised to be between 2° to 25°C. Additional ingredients and dosage recommendations are listed in the text. This solution is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India.*

FDA Label Image

005 (Bimatoprost Ophthalmic Solution 6)

This text provides information on a medication labeled as NDC 60219-2149-2, containing Bimatoprost and Benzalkonium chloride. It recommends a dosage of one drop in the affected eye(s) daily in the evening. The solution is sterile and comes in a 5mL bottle, with storage instructions of 2° to 25°C (36° to 77°F). It is distributed by Amneal Pharmaceuticals LLC and made in India. The packaging also mentions a manufacturing license number.*

FDA Label Image

006 (Bimatoprost Ophthalmic Solution 7)

This is information about Bimatoprost Ophthalmic Solution, a medication used for eye treatment. It contains Bimatoprost as the active ingredient and is administered as one drop in the affected eye(s) once daily in the evening. The solution is sterile and should be stored at a temperature between 2°C to 25°C. The product is manufactured by Amneal Pharmaceuticals in India and distributed in the United States. The package size is 7.5mL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.